1,902
Views
7
CrossRef citations to date
0
Altmetric
Research Paper

Transcriptome-based stemness indices analysis reveals platinum-based chemo-theraputic response indicators in advanced-stage serous ovarian cancer

, , , &
Pages 3753-3771 | Received 15 Apr 2021, Accepted 28 May 2021, Published online: 16 Jul 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Lin Gan, Yongrong Li, Yan Chen, Meihua Huang, Jian Cao, Meiling Cao, Zhihui Wang, Guiping Wan & Tao Gui. (2022) Transcriptome analysis of eutopic endometrial stromal cells in women with adenomyosis by RNA-sequencing. Bioengineered 13:5, pages 12637-12649.
Read now

Articles from other publishers (5)

Hongjin Shi, Zhiyong Tan, Bowen Duan, Chunming Guo, Chong Li, Ting Luan, Ning Li, Yinglong Huang, Shi Chen, Jixian Gao, Wei Feng, Haole Xu, Jiansong Wang, Shi Fu & Haifeng Wang. (2024) LASS2 enhances chemosensitivity to cisplatin by inhibiting PP2A-mediated β-catenin dephosphorylation in a subset of stem-like bladder cancer cells. BMC Medicine 22:1.
Crossref
Jacek Wilczyński, Edyta Paradowska, Justyna Wilczyńska & Miłosz Wilczyński. (2023) Prediction of Chemoresistance—How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer. Current Oncology 31:1, pages 229-249.
Crossref
Ke Ni & Li Hong. (2023) Current Progress and Perspectives of CDC20 in Female Reproductive Cancers. Current Molecular Medicine 23:3, pages 193-199.
Crossref
Zi-Qian Liang, Rong-Quan He, Jia-Yuan Luo, Zhi-Guang Huang, Jie Li, Lu-Yang Zhong, Jun-Hong Chen, Su-Ning Huang, Lin Shi, Kang-Lai Wei, Jiang-Hui Zeng, Jing-Jing Zeng & Gang Chen. (2022) Downregulated Dual-Specificity Protein Phosphatase 1 in Ovarian Carcinoma: A Comprehensive Study With Multiple Methods. Pathology and Oncology Research 28.
Crossref
Hongjun Yuan, Qian Yu, Jianyu Pang, Yongzhi Chen, Miaomiao Sheng & Wenru Tang. (2022) The Value of the Stemness Index in Ovarian Cancer Prognosis. Genes 13:6, pages 993.
Crossref